Dr. Stefano Marullo | Institut Cochin | France
Stefano Marullo, MD, PhD, is an Italian-born physician-scientist recognized for his influential contributions to molecular pharmacology, receptor biology, and innate immunity. Trained in medicine and biochemistry at Université Paris Diderot, he developed a distinguished career spanning clinical practice, fundamental research, academic leadership, and biotechnology innovation. After early roles in internal medicine, hematology, and immuno-hematology within the Paris hospital system, he advanced through prominent research positions at Institut Pasteur and Institut Cochin, where he led pioneering work on receptor signaling, G-protein–coupled receptor regulation, and molecular scaffolding proteins. His career includes international research experience at the University of California, San Francisco, and long-standing service as Principal Investigator and Research Director within INSERM, where he also contributed extensively to academic governance as Vice-Director of a major PhD program and later as Vice-President for Research at Université Paris Descartes. He currently serves as Chief Scientific Officer of ALLSPIM, a pharmaceutical startup developing novel compounds targeting innate immunity homeostasis, while holding the title of Emeritus Research Director at INSERM. Author of more than eighty original research articles in high-impact journals, along with numerous reviews and book chapters, he has earned broad recognition, substantial citation impact, and multiple competitive fellowships and awards reflecting his sustained scientific leadership.
Featured Publications
1. Marullo, S., & Remi, C. (2024). Awakening the thymus to cure SARS-CoV-2 infection: A matter of genes.
2. Da Silva, E., Scott, M. G. H., Enslen, H., & Marullo, S. (2023). Control of CCR5 cell-surface targeting by the PRAF2 gatekeeper.
3. Da Silva, E., Scott, M. G. H., Enslen, H., & Marullo, S. (2023). Control of CCR5 cell surface targeting by the PRAF2 gatekeeper [Preprint].
4. Marullo, S. (2022). Pharmacological chaperone-rescued cystic fibrosis CFTR-F508del mutant overcomes PRAF2-gated access to endoplasmic reticulum exit sites.
5. Chevalier, B., Baatallah, N., Najm, M., Castanier, S., Jung, V., Pranke, I., Golec, A., Stoven, V., Marullo, S., Antigny, F., et al. (2022). Differential CFTR-interactome proximity labeling procedures identify enrichment in multiple SLC transporters.